EntryPoint Capital »

BioCryst Pharmaceuticals shares owned by EntryPoint Capital

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $409k 54k 7.60